Access Statistics for Johann Matthias Graf von der Schulenburg

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Cost of Poor Adherence to Anti-Hypertensive Therapy in Europe 0 0 1 24 0 2 10 132
Cost of poor adherence to anti-hypertensive therapy in five European countries 0 0 0 0 0 2 12 52
Grundlagen und Methoden von GKV-Routinedatenstudien 0 0 0 21 0 4 15 119
Total Working Papers 0 0 1 45 0 8 37 303


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Affirmative and silent cyber coverage in traditional insurance policies: Qualitative content analysis of selected insurance products from the German insurance market 0 0 1 14 0 2 14 144
Amortization of gene replacement therapies: A health policy analysis exploring a mechanism for mitigating budget impact of high-cost treatments 0 0 0 5 0 1 15 27
An Urban Crisis Management System for Critical Infrastructures: Participation Possibilities for Insurance Companies 0 0 2 15 0 1 6 90
Analysis of Driving Factors of Willingness to Use and Willingness to Pay for Existing Pharmacological Smoking Cessation Aids Among Young and Middle-Aged Adults in Germany 0 0 0 2 0 2 5 35
Benefit assessment in Germany: implications for price discounts 0 0 0 5 2 3 9 48
Bonus options in health insurance by Peter Zweifel. Awer Academic Publishers, Dordrecht, 1992. No. of ges: xii + 141. ISBN 0‐7923‐1722‐X 0 0 1 3 0 4 6 14
COVID-19: not the time for health economists? A plea for more proactive health economic involvement 0 0 1 4 0 0 4 20
Cancer management and reimbursement aspects in Germany: an overview demonstrated by the case of colorectal cancer 0 0 0 25 0 0 4 109
Commentary 0 0 0 0 0 3 6 23
Corporate Management of Highly Dynamic Risks: Evidence from the Demand for Terrorism Insurance in Germany 0 0 1 19 5 14 51 107
Correction to: An Urban Crisis Management System for Critical Infrastructures: Participation Possibilities for Insurance Companies 0 0 0 1 0 3 6 19
Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in Germany 0 0 0 2 0 0 4 57
Costs and treatment patterns of incident ADHD patients - a comparative analysis before and after the initial diagnosis - 0 0 0 1 1 5 8 30
Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study 0 0 0 5 0 2 8 82
Diffusion of innovations: treatment of Alzheimer's disease in Germany 0 0 0 39 0 1 6 197
Digital Transformation in Back-Offices of German Insurance Companies 2 2 12 30 3 10 39 86
EJHE has an official impact factor of 1.337 0 0 0 10 0 0 6 123
Editor’s note 0 0 0 2 0 0 2 18
Entwicklung der Leistungsempfängerzahlen in der Gesetzlichen Pflegeversicherung - Zum Einfluss unterschiedlicher Morbiditätsannahmen auf die Entwicklung der sozialrechtlich anerkannten Pflegebedürftigkeit in Deutschland 0 0 1 11 0 3 8 45
German Value Set for the EQ-5D-5L 0 0 1 6 1 4 9 58
German health care system in transition 0 0 0 13 0 1 5 56
Greetings from the Editors 0 0 0 2 1 2 6 31
HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies 0 0 1 19 1 5 10 112
Impact of radiofrequency ablation for patients with varicose veins on the budget of the German statutory health insurance system 0 0 0 6 0 1 7 53
Impact of the Introduction of the Social Long-Term Care Insurance in Germany on Financial Security Assessment in Case of Long-Term Care Need&ast 0 0 1 24 1 1 7 151
Letter from the editors 0 0 0 3 0 0 4 20
Measuring economic consequences of preterm birth - Methodological recommendations for the evaluation of personal burden on children and their caregivers 0 0 0 6 0 2 4 56
Measuring patients’ priorities using the Analytic Hierarchy Process in comparison with Best-Worst-Scaling and rating cards: methodological aspects and ranking tasks 0 0 0 2 0 5 12 31
Nach welchen ökonomischen Methoden sollten Gesundheitsleistungen in Deutschland evaluiert werden? / According to Which Economic Methods Should Health Care Services Become Evaluated in Germany? 0 0 0 13 0 3 6 108
On the Impact of the Financial Crisis on the Dividend Policy of the European Insurance Industry 0 0 0 227 0 6 10 831
Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany 0 0 0 6 0 1 3 73
Promoting vaccinations - an analysis of measures taken by German statutory health insurers 0 0 0 8 0 4 8 49
Rare is frequent and frequent is costly: rare diseases as a challenge for health care systems 0 0 1 7 0 1 7 37
Regional differences in health care of patients with inflammatory bowel disease in Germany 0 0 0 5 1 5 9 53
Reinsurance Brokers and Advice Quality: Is There a Need for Regulation&quest 0 0 0 21 0 1 9 163
Reliability of Risk Management: Market Insurance, Self-Insurance and Self-Protection Reconsidered 0 1 1 48 0 2 7 170
Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe 0 0 0 4 1 4 9 44
Validating the EQ-5D with time trade off for the German population 0 0 0 31 0 0 2 122
Voting on Social Security: The Family as Decision‐Making Unit 0 0 0 3 2 3 6 11
“Market withdrawals” of medicines in Germany after AMNOG: a comparison of HTA ratings and clinical guideline recommendations 0 0 0 5 4 5 11 55
Total Journal Articles 2 3 24 652 23 110 358 3,558


Statistics updated 2026-06-04